Investor Relations

Investor Relations

In this section you can find out more about our investor activities: stock information, financial calendar, presentations, shareholder information and financial reports.

Stock Information

Kiadis Pharma is listed on the regulated market of Euronext Amsterdam and Euronext Brussels since July 2, 2015 under the symbol KDS.
Calendar of events
Interim Report For the six months ended June 30, 2019
Media and investor contact:
Kiadis Pharma

 

Amy Sullivan
Chief Strategy Officer

 

a.sullivan@kiadis.com

Media and investor contact:
Optimum strategic communications

Mary Clark
Supriya Mathur, Hollie Vile
Tel: +44 (0) 203 950 9144

 

kiadis@optimumcomms.com